Head-to-head · WeighScore
Enhance MD vs VevaRX
By GLP-1 ScorecardUpdated
Score comparison
Enhance MD has the higher recorded score — 84.8/100 to 54.7/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Enhance MD | VevaRX |
|---|---|---|
| WeighScore | 84.8/100 | 54.7/100 |
| Grade | B | C |
| Site position | #4 | #503 |
| Semaglutide | $249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) | $189/mo (the same page also prints $167 a month and $467 for three months) |
| Tirzepatide | $329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) | $467 per three months, auto-renewing (about $155.67 a month; no monthly option is offered) |
| Coverage | FAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your address | 36 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #4 · B
Strengths
- Core and Advanced publish separate short- and longer-plan prices with billing periods stated
- Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
- Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
- The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy
What to consider
- Four-week billing and a 48-week longer plan are not twelve calendar-month payments
- First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
- An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
- Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
- One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
- Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
Site position #503 · C
Strengths
- Publishes an exact 36-state list by name rather than a nationwide claim it then hedges
- States what the three-month figure covers — medication, supplies and the provider visit — and includes free two- to three-day shipping
- Unlimited physician access and a 24/7 care team are described as inside the program price
- Prices its peptide products openly beside the GLP-1 lines
What to consider
- Tirzepatide has no monthly option: it is sold as $467 for three months on a quarterly auto-renewal with a three-month minimum
- The tirzepatide page's own arithmetic is wrong — it calls $467 equivalent to $149 a month when the figure is $155.67, which the semaglutide page states correctly
- The semaglutide page carries four prices, two of which belong to tirzepatide
- Follow-up consultations are priced separately at $299 and $399, which the program pages do not mention
- NAD+ is priced three different ways on one page, at $399, $447 and $267
- Another company's domain appears in VevaRX's own Terms, in the transaction currency clause
- The contact page FAQ is a different product's copy and gives dosing instructions for a powdered drink under the question of how to take semaglutide or tirzepatide
- Two opposite return policies are live, and no pharmacy, compounding class, clinician or medical group is named anywhere
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.